Related Experiment Video
Updated: Jul 15, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Consensus definitions proposed for pediatric multiple sclerosis and related disorders
Lauren B Krupp1, Brenda Banwell, Silvia Tenembaum
1National Pediatric MS Center, Stony Brook University Medical Center, Stony Brook, NY 11794-8121, USA. lauren.krupp@stonybrook.edu
Insights
Childhood CNS inflammatory demyelinating disorders, like pediatric multiple sclerosis (MS) and acute disseminated encephalomyelitis (ADEM), can now be clinically defined. Further research is needed to confirm the validity of these new diagnostic categories.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Childhood CNS inflammatory demyelinating disorders present diagnostic challenges due to overlapping symptoms.
- Distinguishing between self-limited and chronic conditions requires a standardized classification system.
- Operational definitions are crucial for advancing research in pediatric demyelinating diseases.
Purpose of the Study:
- To develop consensus definitions for major CNS inflammatory demyelinating disorders in children and adolescents.
- To establish an operational classification system for pediatric demyelinating conditions.
- To facilitate future research and improve diagnostic accuracy.
Main Methods:
- Convened an International Pediatric MS Study Group with multidisciplinary experts.
- Held multiple meetings to reach consensus on diagnostic criteria.
- Utilized clinical, biological, and radiographic data to inform definitions.
Main Results:
- Proposed clinical definitions for pediatric multiple sclerosis (MS), acute disseminated encephalomyelitis (ADEM), recurrent ADEM, multiphasic ADEM, neuromyelitis optica, and clinically isolated syndrome.
- The proposed definitions are considered operational for research purposes.
- These definitions require validation through prospective studies.
Conclusions:
- CNS inflammatory demyelinating disorders in pediatric populations can be defined and differentiated.
- The proposed diagnostic categories need further testing to establish their validity and clinical utility.
- Prospective research is essential for refining these classifications.
Background:
The CNS inflammatory demyelinating disorders of childhood include both self-limited and lifelong conditions, which can be indistinguishable at the time of initial presentation. Clinical, biologic, and radiographic delineation of the various monophasic and chronic childhood demyelinating disorders requires an operational classification system to facilitate prospective research studies.
Methods:
The National Multiple Sclerosis Society (NMSS) organized an International Pediatric MS Study Group (Study Group) composed of adult and pediatric neurologists and experts in genetics, epidemiology, neuropsychology, nursing, and immunology. The group met several times to develop consensus definitions regarding the major CNS inflammatory demyelinating disorders of children and adolescents.
Results:
Clinical definitions are proposed for pediatric multiple sclerosis (MS), acute disseminated encephalomyelitis (ADEM), recurrent ADEM, multiphasic ADEM, neuromyelitis optica, and clinically isolated syndrome. These definitions are considered operational and need to be tested in future research and modified accordingly.
Conclusion:
CNS inflammatory demyelinating disorders presenting in children and adolescents can be defined and distinguished. However, prospective research is necessary to determine the validity and utility of the proposed diagnostic categories.
Related Concept Videos
Multiple Sclerosis l: Introduction
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.

